JPH0535138B2 - - Google Patents
Info
- Publication number
- JPH0535138B2 JPH0535138B2 JP726087A JP726087A JPH0535138B2 JP H0535138 B2 JPH0535138 B2 JP H0535138B2 JP 726087 A JP726087 A JP 726087A JP 726087 A JP726087 A JP 726087A JP H0535138 B2 JPH0535138 B2 JP H0535138B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- amino
- optically active
- azide derivative
- hydroxybutyric acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 150000001540 azides Chemical class 0.000 claims description 9
- 230000003287 optical effect Effects 0.000 claims description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000004429 atom Chemical group 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- -1 t-butoxycarbonyl group Chemical group 0.000 claims description 2
- 238000000034 method Methods 0.000 description 11
- 239000007858 starting material Substances 0.000 description 5
- YQGDEPYYFWUPGO-UHFFFAOYSA-N gamma-amino-beta-hydroxybutyric acid Chemical compound [NH3+]CC(O)CC([O-])=O YQGDEPYYFWUPGO-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 3
- YQGDEPYYFWUPGO-GSVOUGTGSA-N (3r)-4-amino-3-hydroxybutanoic acid Chemical compound NC[C@H](O)CC(O)=O YQGDEPYYFWUPGO-GSVOUGTGSA-N 0.000 description 2
- ASNHGEVAWNWCRQ-UHFFFAOYSA-N 4-(hydroxymethyl)oxolane-2,3,4-triol Chemical compound OCC1(O)COC(O)C1O ASNHGEVAWNWCRQ-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- BRLQWZUYTZBJKN-VKHMYHEASA-N (-)-Epichlorohydrin Chemical compound ClC[C@H]1CO1 BRLQWZUYTZBJKN-VKHMYHEASA-N 0.000 description 1
- BAPRUDZDYCKSOQ-RITPCOANSA-N (2s,4r)-1-acetyl-4-hydroxypyrrolidine-2-carboxylic acid Chemical compound CC(=O)N1C[C@H](O)C[C@H]1C(O)=O BAPRUDZDYCKSOQ-RITPCOANSA-N 0.000 description 1
- ZVNYKZKUBKIIAH-UHFFFAOYSA-N 2-(oxiran-2-yl)acetic acid Chemical compound OC(=O)CC1CO1 ZVNYKZKUBKIIAH-UHFFFAOYSA-N 0.000 description 1
- VSLPYOQEAHSTCW-UHFFFAOYSA-N 2-amino-3-hydroxybutanenitrile Chemical compound CC(O)C(N)C#N VSLPYOQEAHSTCW-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- TVHCXXXXQNWQLP-UHFFFAOYSA-N Dl-threonine methyl ester Chemical compound COC(=O)C(N)C(C)O TVHCXXXXQNWQLP-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 150000004648 butanoic acid derivatives Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP726087A JPS63174959A (ja) | 1987-01-13 | 1987-01-13 | アジド誘導体 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP726087A JPS63174959A (ja) | 1987-01-13 | 1987-01-13 | アジド誘導体 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS63174959A JPS63174959A (ja) | 1988-07-19 |
JPH0535138B2 true JPH0535138B2 (enrdf_load_stackoverflow) | 1993-05-25 |
Family
ID=11661056
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP726087A Granted JPS63174959A (ja) | 1987-01-13 | 1987-01-13 | アジド誘導体 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS63174959A (enrdf_load_stackoverflow) |
-
1987
- 1987-01-13 JP JP726087A patent/JPS63174959A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS63174959A (ja) | 1988-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kobayashi et al. | Catalytic asymmetric syntheses of antifungal sphingofungins and their biological activity as potent inhibitors of serine palmitoyltransferase (SPT) | |
FR2503702A1 (fr) | Nouveaux cycloalcane-amides a substituants adjacents, doues de proprietes analgesiques et compositions pharmaceutiques les contenant | |
DE69009237T2 (de) | Verfahren zur Herstellung von optisch aktiven Estern der 6-t-Butoxy-3,5-dihydroxyhexansäure. | |
JP4015696B2 (ja) | レボブピバカインと同類のピペリジンカルボキサニリド麻酔剤の製造に用いるラセミ化法 | |
DE69901627T2 (de) | Verfahren zur Herstellug von 3-Amino-pyrrolidinderivaten | |
JPH0569818B2 (enrdf_load_stackoverflow) | ||
JPH0535138B2 (enrdf_load_stackoverflow) | ||
EP0869952B1 (fr) | Derives de 5-naphtalen-1-y1-1,3-dioxanes, leur preparation et leur application en therapeutique | |
Chandrasekhar et al. | Synthesis of unusual amino acids: N-(tert-butoxycarbonyl)-l-vinyl glycine and N-(tert-butoxycarbonyl)-l-homophenylalanine | |
JP4012588B2 (ja) | (S)−β−ヒドロキシ−γ−ブチロラクトンの製法 | |
EP0478062A1 (en) | In-situ preparation of diisopinocampheyl chloroborane | |
DE4224342A1 (de) | Verfahren zur Herstellung enantiomerenreiner ß-substituierter Ï-Aminobuttersäurederivate, neue enantiomerenreine Zwischenstufen dieses Verfahrens und deren Verwendung | |
WO2019228874A1 (en) | Stereoselective synthesis of enantiomerically-enriched pantolactone | |
Kise et al. | Diastereoselective intermolecular coupling of chiral α-imino amides with ketones by electroreduction | |
KR102700997B1 (ko) | (2S, 5R)-벤질-5-(t-부톡시카르보닐아미노)-2-메틸피페리딘-1-카르복실레이트의 제조방법 | |
DE4128345C1 (en) | 3R,5S 3,5,6-tri:hydroxy-hexanoic acid isopropylidene ketal derivs. prepn. - from 7-benzyl:oxy 4,6-di:hydroxy:heptene by multistage process | |
JPS63316759A (ja) | 4−アジド−3−ヒドロキシブチロニトリルの製法 | |
JP2640519B2 (ja) | 有機ゲルマニウム化合物及びその製造方法 | |
FR2741071A1 (fr) | Derives de 3-(benzofuran-5-yl)oxazolidin-2-one, leur preparation et leur application en therapeutique | |
JPS5940839B2 (ja) | 混合酸型1,2−ジアシル−3−グリセリルホスホリルコリン類の製法 | |
JPH02289537A (ja) | 光学活性6―t―ブトキシ―3,5―ジヒドロキシヘキサン酸エステルの製造法 | |
BE829176R (fr) | Nouveaux acides carboxyliques et procede pour les preparer | |
JPS6165878A (ja) | 5−0−置換−2−デオキシキシロノ−1,4−ラクトンおよびその製造方法 | |
EP3819295A1 (en) | Stereoselective synthesis of enantiomerically-enriched pantolactone | |
DE3650023T2 (de) | Beta-Lactamverbindungen und deren Herstellung. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |